Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Barbato

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Proteins|October 2, 2019
Introducing "best single template" models as reference baseline for the Continuous Automated Model Evaluation (CAMEO)Juergen Haas, Rafal Gumienny, Alessandro Barbato, et al.
Frontiers in Oncology|January 7, 2021
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An OverviewAlessandro Barbato, Grazia Scandura, Fabrizio Puglisi, et al.
Endocrine Connections|August 30, 2024
Endocrinological features and epileptic encephalopathy in COX deficiency due to SCO1 mutations: case series and review of literatureAlessandro Barbato, Giulia Gori, Michele Sacchini, et al.
Cell Death & Disease|October 30, 2019
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myelomaCesarina Giallongo, Daniele Tibullo, Giuseppina Camiolo, et al.
Cell Death & Disease|September 22, 2019
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myelomaCesarina Giallongo, Daniele Tibullo, Giuseppina Camiolo, et al.
Antioxidants (Basel, Switzerland)|February 25, 2022
The Crosstalk between GPR81/IGFBP6 Promotes Breast Cancer Progression by Modulating Lactate Metabolism and Oxidative StressLucia Longhitano, Stefano Forte, Laura Orlando, et al.
Antioxidants (Basel, Switzerland)|June 26, 2025
Correction: Longhitano et al. The Crosstalk between GPR81/IGFBP6 Promotes Breast Cancer Progression by Modulating Lactate Metabolism and Oxidative Stress. <i>Antioxidants</i> 2022, <i>11</i>, 275Lucia Longhitano, Stefano Forte, Laura Orlando, et al.
Cancers|July 26, 2020
Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma CellsCesarina Giallongo, Daniele Tibullo, Fabrizio Puglisi, et al.
Cancers|February 6, 2020
Ixazomib Improves Bone Remodeling and Counteracts sonic Hedgehog signaling Inhibition Mediated by Myeloma CellsDaniele Tibullo, Anna Longo, Nunzio Vicario, et al.
Cell Proliferation|February 16, 2023
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myelomaAlessandro Barbato, Cesarina Giallongo, Sebastiano Giallongo, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Proteins|October 2, 2019
Introducing "best single template" models as reference baseline for the Continuous Automated Model Evaluation (CAMEO)Juergen Haas, Rafal Gumienny, Alessandro Barbato, et al.
Frontiers in Oncology|January 7, 2021
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An OverviewAlessandro Barbato, Grazia Scandura, Fabrizio Puglisi, et al.
Endocrine Connections|August 30, 2024
Endocrinological features and epileptic encephalopathy in COX deficiency due to SCO1 mutations: case series and review of literatureAlessandro Barbato, Giulia Gori, Michele Sacchini, et al.
Cell Death & Disease|October 30, 2019
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myelomaCesarina Giallongo, Daniele Tibullo, Giuseppina Camiolo, et al.
Cell Death & Disease|September 22, 2019
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myelomaCesarina Giallongo, Daniele Tibullo, Giuseppina Camiolo, et al.
Antioxidants (Basel, Switzerland)|February 25, 2022
The Crosstalk between GPR81/IGFBP6 Promotes Breast Cancer Progression by Modulating Lactate Metabolism and Oxidative StressLucia Longhitano, Stefano Forte, Laura Orlando, et al.
Antioxidants (Basel, Switzerland)|June 26, 2025
Correction: Longhitano et al. The Crosstalk between GPR81/IGFBP6 Promotes Breast Cancer Progression by Modulating Lactate Metabolism and Oxidative Stress. <i>Antioxidants</i> 2022, <i>11</i>, 275Lucia Longhitano, Stefano Forte, Laura Orlando, et al.
Cancers|July 26, 2020
Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma CellsCesarina Giallongo, Daniele Tibullo, Fabrizio Puglisi, et al.
Cancers|February 6, 2020
Ixazomib Improves Bone Remodeling and Counteracts sonic Hedgehog signaling Inhibition Mediated by Myeloma CellsDaniele Tibullo, Anna Longo, Nunzio Vicario, et al.
Cell Proliferation|February 16, 2023
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myelomaAlessandro Barbato, Cesarina Giallongo, Sebastiano Giallongo, et al.
Pageof 3